Cargando…

High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case

Detalles Bibliográficos
Autores principales:	D’Angiò, Mariella, Fazio, Grazia, Grioni, Andrea, Palamini, Sonia, Sala, Simona, Galbiati, Marta, Biondi, Andrea, Balduzzi, Adriana, Rizzari, Carmelo, Cazzaniga, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643912/ https://www.ncbi.nlm.nih.gov/pubmed/33163906 http://dx.doi.org/10.1097/HS9.0000000000000471

Ejemplares similares

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
por: Tanaka, Atsushi, et al.
Publicado: (2022)

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
por: Birdwell, Christine, et al.
Publicado: (2021)

EVI1 in Leukemia and Solid Tumors
por: Liang, Beiyuan, et al.
Publicado: (2020)

Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia
por: Glass, Carolyn, et al.
Publicado: (2013)

RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks
por: Kellaway, Sophie G., et al.
Publicado: (2020)

EVI1-mediated Programming of Normal and Malignant Hematopoiesis
por: Lux, Susanne, et al.
Publicado: (2023)

EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis
por: Tanaka, Mariko, et al.
Publicado: (2017)

EVI1 as a Marker for Lymph Node Metastasis in HNSCC
por: Idel, Christian, et al.
Publicado: (2020)

EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2
por: Gómez-Benito, M, et al.
Publicado: (2010)

Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2018)

S116: CELLULAR AND MOLECULAR MECHANISMS OF EVI1-EXPRESSING MLL-REARRANGED ACUTE MYELOID LEUKEMIA
por: Châtel-Soulet, Hugues-Etienne, et al.
Publicado: (2022)

EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
por: Ayoub, Edward, et al.
Publicado: (2018)

Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
por: Brooks, D. J., et al.
Publicado: (1996)

EVI-1 acts as an oncogene and positively regulates calreticulin in breast cancer
por: Wu, Lei, et al.
Publicado: (2019)

EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer
por: Kim, Hwa-Ryeon, et al.
Publicado: (2021)

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
por: Sato, T, et al.
Publicado: (2014)

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
por: Paubelle, Etienne, et al.
Publicado: (2019)

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
por: Zheng, Yongzhi, et al.
Publicado: (2021)

The role of Evi/Wntless in exporting Wnt proteins
por: Wolf, Lucie, et al.
Publicado: (2023)

Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation
por: Mizuno, Hideaki, et al.
Publicado: (2021)

Arsenic trioxide induces apoptosis in the THP1 cell line by downregulating EVI-1
por: ZHOU, LING-YUN, et al.
Publicado: (2014)

Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia
por: Severgnini, Marco, et al.
Publicado: (2022)

Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
por: Konrad, Torsten A., et al.
Publicado: (2009)

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid
por: Steinmetz, Birgit, et al.
Publicado: (2014)

Mutation at the Evi1 Locus in Junbo Mice Causes Susceptibility to Otitis Media
por: Parkinson, Nicholas, et al.
Publicado: (2006)

Evi1 forms a bridge between the epigenetic machinery and signaling pathways
por: Yoshimi, Akihide, et al.
Publicado: (2011)

[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer
por: Wu, Lei, et al.
Publicado: (2023)

ERAD‐dependent control of the Wnt secretory factor Evi
por: Glaeser, Kathrin, et al.
Publicado: (2018)

Evi5 is required for Xenopus limb and tail regeneration
por: Yang, Li, et al.
Publicado: (2022)

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops
por: Ottema, Sophie, et al.
Publicado: (2021)

RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study
por: Shen, Lijing, et al.
Publicado: (2015)

miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1
por: Wu, Lei, et al.
Publicado: (2018)

EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle
por: Paredes, Roberto, et al.
Publicado: (2020)

EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase
por: Saito, Yusuke, et al.
Publicado: (2020)

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
por: Palomero, Luis, et al.
Publicado: (2020)

Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
por: Kiehlmeier, Sandra, et al.
Publicado: (2021)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
por: Leichsenring, Jonas, et al.
Publicado: (2022)

EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
por: Grandits, Alexander Michael, et al.
Publicado: (2022)

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
por: Cai, Tingting, et al.
Publicado: (2020)

EVI1 Inhibits Apoptosis Induced by Antileukemic Drugs via Upregulation of CDKN1A/p21/WAF in Human Myeloid Cells
por: Rommer, Anna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gl46a777ahlca146vfloqjhncl